Moderate therapeutic hypothermia procedures are used in post-cardiac arrest care, while in surgical procedures, lower core temperatures are often utilized to provide cerebral protection. Involuntary reduction of core body temperature takes place in accidental hypothermia and ventricular arrhythmias are recognized as a principal cause for a high mortality rate in these patients. We assessed both clinical and experimental literature through a systematic literature search in the PubMed database, to review the effect of hypothermia on cardiac electrophysiology. From included studies, there is common experimental and clinical evidence that progressive cooling will induce changes in cardiac electrophysiology. The QT interval is prolonged and appears more sensitive to decreases in temperature than the QRS interval. Severe hypothermia is associated with more pronounced changes, some of which are proarrhythmic. This is supported clinically where severe accidental hypothermia is commonly associated with ventricular fibrillation or asystole. J-waves in human electrocardiogram recordings are regularly but not always observed in hypothermia. Its relation to ventricular repolarization and arrhythmias is not obvious. Little clinical data exist on efficacy of anti-arrhythmic drugs in hypothermia, while experimental data show the potential of some agents, such as the class III antiarrhythmic bretylium. It is apparent that QT-prolonging drugs should be avoided.
Introduction
Hypothermia can be accidental or a therapeutic measure to lower metabolic demands and protect against hypoxic damage. The impact of hypothermia could be more severe when comorbidities exist. 1 Therapeutic temperature management is used after severe injury or disease such as cardiac arrest. Comatose survivors are cooled to below 36 C, although doubt has been raised whether more profound cooling is beneficial. Avoiding hyperthermia could be the principal mechanism for providing neuroprotection in these patients. 2 In trauma patients, hypothermia has a negative impact, giving three-fold increase in mortality. 3 The degree of cooling varies greatly between types of accidental or therapeutic exposure. Based on clinical studies, hypothermia has been classified into three broad categories: mild [34] [35] C, moderate 30-34 C, and severe <30 C. 1 The overall mortality of accidental hypothermia is estimated between 25% and 40% in most studies 4, 5 and arrhythmias are a major concern both during cooling and rewarming. Submersion and immersion hypothermia deaths could incorrectly be ascribed to drowning, with patients succumbing to hypothermia induced arrhythmias or an autonomic conflict. It is hypothesized that ventricular arrhythmia can arise from a simultaneous activation of the diving response and cold shock; triggering a parasympathetically driven bradycardia, and sympathetically driven tachycardia. 6 Detailed measurements of cardiac electrophysiology during hypothermia are challenging to obtain. Invasive electrical measurements provide higher resolution and more detailed regional information. Due to these benefits, experimental studies give important information. However, a large proportion of such studies are carried out at room temperature, thus only observing electrophysiology at temperatures corresponding to severe hypothermia, without comparing findings to normothermic conditions. [7] [8] [9] Therefore, it is important to assess literature that compares electrophysiology at both low and normal core temperatures. Cardiac electrophysiology is largely species-dependent, with hibernators being resistant to lethal ventricular fibrillation (VF). 10 Comparison and critical review of experimental and clinical findings is therefore essential for a better understanding of the proarrhythmic impact of hypothermia.
Methods
A systematic literature search was conducted on 27 March 2017 in the electronic PubMed database. All articles retrieved for: #1 Hypothermia AND electrophysiology, and #2 hypothermia AND ECG, were assessed. A total of 1412 publications were identified. The main criterion for inclusion was that they had a hypothermia protocol and a measure of cardiac electrophysiology. Case reports, studies in children and neonates, studies on non-mammals, studies in which hypothermia was induced with drugs or local injection of cold fluids, regional cooling of hearts and studies where cardioplegic solutions were used prior to cooling, were excluded.
Studies were considered for inclusion based on the abstract. If this was inadequate or absent, the full text was assessed to examine whether they met inclusion criteria. A total of 86 studies were included, of which 38 were clinical and the remainder were experimental in different species. Articles that were not detected through the literature search were found in reference-lists of included papers or other literature reviews.
Ventricular action potential and ion-channels
To initiate an action potential (AP) and subsequent contraction of resting ventricular cardiomyocytes (Phase 4 of the AP), depolarization must be initiated by increased sodium conductance via voltage-gated Na þ -channels (Phase 0) ( Figure 1 , Table 1 ). In severe hypothermia (27 C) sodium current appears impaired, 11 thus prolonging Phase 0. Phase 1 is initiated by rapid inactivation of the Na þ -channels and activation of a transient outward current (I to ) . This leads to a transient increase in potassium conductance, causing the rapid and transient repolarization seen as the AP notch. Some studies suggest a heterogenic effect of hypothermia on I to 12 with a larger epicardial outward potassium current, causing a more prominent epicardial AP notch. 13 Phase 1 is followed by the plateau phase (Phase 2), where the membrane potential is more stable and repolarization is slowly initiated by opening of delayed rectifier K þ -channels, increasing membrane potassium conductance. Simultaneously, calcium influx is initiated due to opening of L-type Ca 2þ channels. In severely hypothermic cardiomyocytes, the transient calcium influx during Phase 2 is prolonged and the cytosolic calcium concentration is increased. 14 During Phase 3, the L-type Ca 2þ channels close, while the delayed rectifier K þ -channels remains open. Thus, a change in membrane potential to more negative potentials occurs and which engages the background inwardly rectifying K þ conductance, contributing to repolarization of the cardiomyocyte. Both delayed and inward rectifying K þ -channel function appears temperature-sensitive. A reduction in core temperature will therefore impair potassium channel function and prolong Phase 2 and 3. 11, 15, 16 In general, ion-channel function is severely affected by hypothermia and studies aiming to describing normothermic electrophysiology, should not be carried out at room temperature.
Atrial depolarization and atrioventricular conduction 4.1 Experimental studies
In electrocardiogram (ECG) recordings, atrial depolarization underlies the P-wave, while ventricular depolarization underlies the QRS complex and the PR interval reflects conduction through the atrioventricular (AV) node ( Figure 1 , Table 1 ). PR interval prolongation can occur in different pathological situations; typically AV-block. 17 In hypothermic dogs the PR interval became prolonged after cooling to 29 C 18 and was doubled at 24 C. 19 PR prolongation is smaller in monkeys, with a 11-38% change during cooling to 25 C. 20 In hibernating squirrels, where core temperature fell below 11 C, PR interval was prolonged by a factor of 7.
The T-P segment (representing diastole) was increased 40-70 times, underlying pronounced bradycardia. 21 While heart rate is decreased, interbeat interval variability is increased in hypothermic rat hearts during cooling to 27 C. The authors concluded that this change was attributed to the sino-atrial (SA) node. Regularity of discharge of pacemaker cells was impaired by low temperature, while AV conduction appeared unaffected. 22 However, in vivo cooling does produce conduction disturbances spanning from first degree AV block to total heart block. [23] [24] [25] In rats, these disturbances present through a sudden increase in PR interval at 22 C. If rats received respiratory support, such block was delayed to below 18 C. Subsequently, atrial arrest would occur prior to ventricular arrest. 26 In isolated rabbit atria, arrest occurs after cooling to 21 C. 27 
Clinical studies
Bradycardia is a well-known effect of cooling but is not always observed during moderate hypothermia. Fifteen accidental hypothermia patients in sinus rhythm, with an average core temperature of 30.5 C, had heart rates ranging from 13 b.p.m. to 100 b.p.m. 28 A sympathetically mediated increase second to initial cooling, could contribute to large variations in heart rate. In sedated patients, subjected to therapeutic hypothermia, bradycardia seems more consistent. Patients cooled to a target of 33 C had an average heart rate reduction of 19 b.p.m. 29 During cooling to 28-30 C, 7 of 13 patients had prolonged PR interval. 30 Although some reports find unchanged PR interval after cooling, 31 it is generally increased in therapeutic hypothermia. 29, [32] [33] [34] [35] Hypothermia-induced PR prolongation is found in some, 36, 37 but not all 38, 39 ECG studies during rewarming from accidental hypothermia. In severely hypothermic patients, Darocha et al. 37 found low P-wave amplitude (0.1 mV), while Kim et al. 31 found unchanged (0.16 mV) amplitude at 33.5 C.
Serious AV-nodal pathology is not observed in all studies. Only 3 of 25 Scottish accidental hypothermia patients (mean core temperature: 30.3 C) presented with varying degrees of AV block. 28 In a Brazilian study, AV block was seen in 3 of 59 patients but only 10 patients had core temperatures below 28 C. 36 Severe accidental hypothermia does however promote AV block. 40, 41 This relationship is also observed in patients subjected to direct cardiac cooling. 42 
Summary
Hypothermia induces bradycardia and prolongs AV nodal conduction, as observed by elongated PR interval. Severity can span from first degree AV-block to total heart block and is dependent on temperature reduction. These effects are demonstrated more clearly below 20 C in experimental animal models, compared with human studies of moderate hypothermia.
Ventricular depolarization

Experimental studies
During hypothermia, reduced conductance of Na þ -channels is reflected by reduced maximum rate of depolarization in guinea-pig papillary ( Figure 1 , Table 1 ). Hypothermia-induced prolongation of depolarization is reflected in ECG recordings. In rats, ventricular activation time (QR time) increased during progressive cooling to cardiac arrest. 44 
Clinical studies
QRS duration appears increased in severe accidental and therapeutic hypothermia. 33, 37 In moderate hypothermia, there are reports of prolonged QRS duration, 31, 34 but it is more often unaffected or decreased. 29, 38, 39, [45] [46] [47] Lam et al. 29 found an 8 ms (7%) decrease in QRS interval of 101 cardiac arrest survivors at 33 C, indicating increased endocardial to epicardial conduction. Interestingly, there was a trend towards non-survivors having shorter QRS interval compared with survivors (P < 0.1). After cooling to 28-30 C, 7 of 13 patients had prolonged QRS interval. 30 
Summary
Progressive cooling slows ventricular depolarization. This effect appears to be non-linear and is only consistently observed after cooling below 30 C, which appears to be a threshold temperature for this effect. Some studies even suggest faster depolarization during moderate hypothermia in humans. 29 6. Ventricular repolarization
Experimental studies
Lengthening of cardiac repolarization is a prominent feature of cooling 11 ( Figure 1 , Table 1 ). Studies in isolated cardiomyocytes indicate that both I K and I K1 -channels are temperature-sensitive. 11, 15, 16 Impaired potassium conductance mediates prolonged repolarization, reflected in QTinterval of the ECG signal. In dogs cooled to 34.2 C 48 and rats cooled to cardiac arrest, QTc interval was prolonged in a linear relationship with decreasing core temperature. Cooling-induced QT prolongation is also observed in rats, 44 cats, 49 and rabbit hearts. 50 Siems et al. 51 reported that after the initial prolongation of QTc, a threshold was reached, thereafter no change occurred during further cooling of dogs. Further, epicardial mapping of intact rabbit hearts at 32 C, showed nonuniform repolarization-changes, which was particularly pronounced at the left ventricular (LV) apex. 52 When studying action potential duration (APD) Figure 1 A schematic drawing of a human AP and ECG signal during normothermia and hypothermia. Reduction of core temperature appears to have a heterogenic effect of depolarization (Phase 0 of the AP and QRS interval of the ECG) and repolarization (Phase 2-3 of the AP and QT-interval of the ECG). During moderate hypothermia depolarization is largely unaffected or shortened, while repolarization is prolonged. In severe hypothermia, both depolarization and repolarization is prolonged. Several ECG findings could be found in hypothermic patients and are reflected in the AP. Dispersion of beat-to-beat QT interval indicated dispersed repolarization, while appearance of J-waves during hypothermia could be caused by a transmural heterogeneity in Phase 1 repolarization, with a large epicardial notch. It is also enhanced in hypothermic guinea-pig hearts. 54 Repolarization is more slowed by hypothermia (32 C) in Purkinje fibres than in ventricular cardiomyocytes. This is thought to found basis for the U-wave, occurring after the T-wave in ECG recordings. 55 Further, mathematical simulation indicate that prolonged epicardial APD and unchanged endocardial APD, could explain increased transmural repolarization gradient during hypothermia. 56 However, in canine right ventricular preparations, Phase 1 epicardial repolarization is enhanced at 32 C. 12 Hibernating hedgehogs that lack a physiological AP plateau phase seem less vulnerable to hypothermia than guinea-pigs, where slow conduction and dispersion of repolarization is more apparent after cooling to 15 C. 57 This could explain why hedgehogs rarely develop VF during hypothermia. 58 
Clinical studies
Clinical ECG studies in therapeutic and accidental hypothermia show consistent increased QTc interval and thus prolonged repolarization, mainly without QRS interval change. 29, [31] [32] [33] [34] [35] [36] [37] [38] [39] [45] [46] [47] [59] [60] [61] [62] [63] Prolongation of QTc 64, 65 in presence of unchanged QRS interval is also found in patients with acquired poikilothermia (average core temperature 33.9 C). 64 Fast induction of therapeutic hypothermia gives a larger increase in QTc duration than slow cooling. 47 No relation to increased incidence of arrhythmias or mortality was however found in a study on therapeutic hypothermia patients. 29 Despite this, cooling of patients with long QT syndrome should be done with great caution 34 as rate of repolarization appears more temperature-sensitive than rate of depolarization. T-wave flattening or inversion can also occur during cooling, sometimes in concert with increased J-wave amplitude. 32 Flattening or inversion of T-waves occurred in 8 of 13 patients cooled prior to neurosurgery 30 and was the most common ECG finding during duodenal ulcer-treatment with gastric hypothermia. 66 Increased dispersion of repolarization is found in animal models after cooling below 32 C 53,54,57 and is associated with ventricular arrhythmias.
In ECG recordings, the interval from peak to end of the T-wave (TpTe), can be used as a marker of transmural dispersion of repolarization. Kim et al. 31 did not find any significant change in TpTe after therapeutic cooling of patients to 33.5 C. In accidental hypothermia patients however, increased QTc dispersion was found. 38 
Summary
Cardiac repolarization is prolonged with an approximately linear relationship with decreasing core temperature and is evident during early cooling. This is basis for the consistent QTc-prolongation observed in both therapeutic and accidental hypothermia in humans.
J-wave
The J-wave is a hypothermia-associated deflection between the end of the QRS complex and the beginning of the ST segment. Although first described by Tomaszewski in 1938, 67, 68 it is often named the Osbornwave, after an experimental dog study from 1953 ( Figure 1 , Table 1 ). The appearance of a J-wave at 25 C was described as 'a current of injury' and correlated to the later onset of VF, 69 a finding that was supported by 72 In transmural, canine wedgepreparations, hypothermia-induced J-waves is associated with a prominent AP notch only in the epicardium. This suggests a heterogeneous distribution of transient outward current (I to ) that underlies the occurrence of J-waves. 13 Findings from Morita et al. 12 concur with this theory, as blocking of I to with 4-aminopyridine, reduced J-wave elevation at 32 C. In a canine wedge preparation model, J-waves were increased during cooling to 32 C. Simulating early repolarization syndrome during hypothermia, accentuated the epicardial AP notch. 73 
Clinical studies
The proportion of hypothermic patients presenting with J-waves varies greatly between studies and is temperature dependent. J-waves occurred in 100% of patients with core temperatures below 32 C 75 or 30 C. 74 This is in accordance with a study on induced hypothermia prior to surgery. 9 of 60 patients developed J-waves, which with one exception, was first observed after cooling below 30 C. 70 A temperaturedependent relationship is not clear in all accidental hypothermia studies. Darocha et al. 37 found J-waves in only 3 of 19 patients with core temperatures below 26.2 C and Durakovi c showed that >70% of elderly patients presented with J-waves both at temperatures between 32 C and 35 C and below 32 C. 38, 63 Vectorcardiographic recordings show the three-dimensional direction of electrical conduction in the heart. After cooling, a J-loop deflection related to J-wave occurrence appeared in five therapeutic (30.5-31.5 C) 76 and 23 accidental hypothermia patients (22.8-34.4 C). 77 Further, J-wave amplitude seems inversely correlated with core temperature-reduction, 36, 75, 78 but an association with ventricular arrhythmias is not supported by all clinical studies. In 30 accidental hypothermia patients (29.4-33.5 C) with J-waves, only one developed ventricular tachycardia (VT) 74 and J-waves does not predict survival chance. 39 A multicentre study from South Korea observed J-waves in 41% of therapeutic hypothermia patients, while VF only occurred in 1.7%, 79 which concurs with other studies. 80 J-waves are more common in hypothermic ST-elevation myocardial infarction (STEMI) (38.6%) than non-STEMI (15.2%) patients. 45 Further, Williams et al. 81 reported that early repolarization and J-waves are more common in survivors of idiopathic (100%) than coronary artery disease-associated VF (66.7%). This reflects on underlying differences in cardiac pathophysiology and necessitates careful cooling of patients vulnerable to early repolarization.
Summary
The likely cause of the J-wave is late and slow depolarization of a significant region of the ventricle immediately after the QRS complex, or conversely an early repolarization of an area of the ventricle. Both cases create an area of the ventricle that is polarized relative to the remainder. In both human and experimental studies, the occurrence of J-waves, and the temperatures at which it arises, varies greatly. Although postulated by Osborne, 69 there is apparently no consistent relationship between presence of J-waves and risk for ventricular arrhythmias during hypothermia.
Incidence of arrhythmias during cooling 8.1 Experimental studies
During progressive cooling of 15 dogs, cardiac arrest occurred after VF in 60% of animals 51 ( Table 1) . During VF, cooling does not affect intramyocardial voltage 82 but VF morphology is changed. 83 Further, compared with at 37 C and 30 C, spiral wave excitations are more disorganized at 33 C. Optical mapping showed that such disorganization favoured spiral wave collision and self-termination of VT/VF. 84 These findings concur with pig experiments showing that successful defibrillation from VF was achieved more often at 33 C, than at 30 C, or 37 C. 85 Cooling to 30 C however, enhanced epicardial APD dispersion, wavebreaks and re-entry, thus increasing the vulnerability to pacing-induced VF, 86 similar to studies in other dog 87 and pig models. 88 Reduced VFthreshold is found in concert with electrical alternans, detected in both QRS complex and T-waves. 89, 90 VF-risk appears dependent on cooling method. Smith et al. investigated whether hemodilution during therapeutic hypothermia could be beneficial. They showed that rapid cooling to 20 C in non-hemodiluted dogs resulted in cardiac arrest in 50% of animals, 91 similar to findings of Wynne et al. 92 In dogs hemodiluted with 50% of their calculated blood volume replaced by Ringer's lactate solution, cardiac arrest (VF) occurred in only 5%. 91 Rapid and profound cooling could however also terminate VF in vitro, as found by Chorro et al. 93 in rabbit hearts that were perfused with cold (4 C), oxygenated Tyrode's solution. Cardiac vulnerability is promoted further by rewarming. In canine wedge preparations cooled to 26 C, VF and VT was more frequent during rewarming than cooling. 53 In a similar model, simulating early repolarization syndrome, hypothermia (32 C) caused local re-excitation and polymorphic VT/VF. 73 Development of VF during hypothermia and rewarming could be triggered by adrenergic stimuli. In a feline model of hypothermia, ventricular arrhythmias were triggered in 100% of hearts when adrenaline, noradrenaline, or isoprenaline were provided at 21 C, in doses that were safe at 37 C. 94 
Clinical studies
Risk for ventricular arrhythmias is dependent of severity of hypothermia and pose a significant challenge during rewarming. Of 19 accidental hypothermia patients, admitted with core temperatures between 16.9 C and 29 C, seven were in VF, while two presented with asystole. 37 In a Japanese study of 60 patients, however, no patients with a core temperature above 26 C had VF. 95 In urban accidental hypothermia, underlying conditions and substance abuse can be as important predisposing factors for cardiac arrest as core temperature. 61 In therapeutic hypothermia, ventricular ectopic activity is increased 96 and non-sustained VT can occur frequently, 34 but sustained ventricular arrhythmias are uncommon in most 34, 35, 45, 62, 79 but not all studies. Mirzoyev found polymorphic VT in 11.7% of therapeutic hypothermia patients. VT onset occurred at an average of 34.7 C during cooling in patients that were hypokalaemic and had QTc interval-prolongation. 46 When VF is induced during cooling prior to coronary surgery, fibrillation frequency is significantly higher if induced at 34 C, compared with at 30 C. Further, Strohmenger et al. 97 found that defibrillation success increased if fibrillation frequency was allowed to increase above 5 Hz, prior to counter-shock attempts during rewarming.
Atrial fibrillation (AF) is reported to have high incidence in several accidental 61, 63, 75, 98 and therapeutic hypothermia studies. 34, 45 Some reports suggest otherwise, most notably in a recent study where only 2 of 59 accidental hypothermia patients presented with AF. 36 Like ventricular
arrhythmias, onset appears temperature-dependent. In a study from Tokyo, 1 of 18 accidental hypothermia patients with core temperature above 32 C and 23 of 42 patients with temperatures below 32 C presented with AF. 95 During therapeutic cooling in preparation for neurosurgery, AF occurred at a mean temperature of 28.9 C. 32 Graham et al. 39 associated onset of AF during accidental hypothermia with a poor prognosis, as 60% of patients presenting with this rhythm died. Earlier findings are conflicting. In 25 patients cooled for cardiac surgery, mortality rate was 29% when AF was observed, compared with 75% in patients in sinus rhythm. 99 
Summary
Vulnerability for ventricular arrhythmias in animal models seem dependant on cooling method and is promoted by adrenergic stimuli. In humans, VF or asystole is more common in accidental hypothermia patients admitted with low core temperatures. Serious ventricular arrhythmias are uncommon in therapeutic hypothermia.
Pharmacological treatment
Few clinical studies have examined the properties of antiarrhythmic agents during hypothermia and rewarming. Although limited, most evidence is provided by preclinical studies using various species.
Class I antiarrhythmic agents
Quinidine is a Class I antiarrhythmic agent and blocks voltage-gated Na þ -channels. It also blocks I to , which prevents loss of AP dome during cooling to 32 C in canine wedge preparations. Thus, in presence of this pathophysiological substrate for re-excitation and Phase 2 re-entry during hypothermia, quinidine prevented development of VT/VF. 73 Another Na þ -channel blocker; procainamide prolonged PR-and QT intervals during cooling in dogs and evaluation of its antiarrhythmic effect was inconclusive. 100 
Class III antiarrhythmic agents
Bretylium possess antiadrenergic activity through sympathetic ganglion blockade. It is also a K þ -channel blocker. On the hypothesis that cooling would promote ventricular arrhythmias through increased adrenergic activity, effects of bretylium were studied during rewarming from 25 C in dogs. Although plasma catecholamine levels remained unchanged, bretylium increased VF-threshold. 101 The same antiarrhythmic effects are found after cooling to 27 C 102 and during rewarming from 24 C. 103 However, these positive effects of bretylium might be limited to preventive treatment. Antiarrhythmic effects were not found during rewarming of dogs in VF. In the latter study, defibrillation was attempted following 10 min of CPR following drug administration at 22 C, the animals were not actively rewarmed before defibrillation. 104 At such temperatures, defibrillation is challenging independent of treatment. 105 Amiodarone has diverse effects, among them is K þ -channel blockade and it therefore prolongs repolarization. In amiodarone-treated dogs with VF at 22 C, 1/10 were successfully resuscitated. Resuscitation rate was 4/10 in bretylium treated, and 3/10 in placebo-treated animals. 104 This indicates that pharmacological APD prolongation during hypothermia is unfavourable. A study on K þ -channel blocker sotalol gave the same outcome; sotalol-treatment was more effective in prolonging APD during hypothermic than normothermic conditions and authors thought this effect to be pro-arrhythmic.
11,106
Class IV antiarrhythmic agents
The Class IV antiarrhythmic agent diltiazem is a Ca 2þ -channel blocker which shortens APD. Bjørnstad et al. found a progressive AP prolongation during cooling to 25 C, in concert with reduced VF-threshold.
Addition of diltiazem failed to increase VF-threshold in hypothermic dogs. At 27 C, the Ca 2þ -channel blocker nisoldipine also shortened APD to within normothermic values in isolated guinea-pig papillary muscle. 107 
Other pharmacological agents
In an early repolarization syndrome model, phosphodiesterase III inhibitors milrinone and cilostazol were used to increase cAMP and thus augment the inward Ca 2þ current (I ca ), which prevented Phase 2 re-entry and VT/VF during cooling to 32 C. 73 In intact cardiomyocytes, dopamine will also increase cAMP through b-receptor stimulation. In excised muscle strips from pig ventricular septum, dopamine prolonged APD at 32 C. 108 Regulation of Ca 2þ-homeostasis could therefore be promising in treatment of hypothermia-induced arrhythmias. In a canine model of hypothermia, dipyridamole is thought to mediate such effect 109 and reduced the core temperature of which dogs would go into VF. 110 Fluid treatment with low or high molecular weight dextran did not have any effect on the ECG of dogs cooled to 20-22 C. 111 Further, benzodiazepines such as diazepam produce Ca 2þ -channel blockade and has been tested in a guinea-pig model of hypothermia, to explore potential anti-arrhythmic effect. However, significant shortening of APD was only obtained by a 100 mM dose and the effect was subtle compared with the Ca 2þ channel blocker nisoldipine. It was therefore concluded that diazepam has little clinical potential in prevention of arrhythmias in hypothermic patients. 107 
Summary
Little information on the effect of antiarrhythmic treatment exists from clinical hypothermia studies, but preclinical reports suggest favourable properties of some drugs. Quinidine and other Na þ -channel blockers could prevent VF by inhibiting hypothermia-induced Phase 2 re-entry. Further, bretylium prevents VF in dogs suffering severe hypothermia, probably attributed to its antiadrenergic effects.
Conclusion and clinical recommendations
The impact of hypothermia on cardiac electrophysiology largely depends on the extent of cooling and resultant core temperature. Severe cooling generates more profound changes as reported in both clinical and experimental studies. Interestingly, the observed changes are not uniform. In clinical studies, prolongation of QT interval is observed during cooling to moderate therapeutic hypothermia, while the temperature-dependent effects on QRS-and PR intervals are inconsistent. Accordingly, repolarization seems more vulnerable to smaller changes in temperature. Experimental studies reflect these findings and show a heterogenic prolongation of repolarization both on the epicardial surface and transmurally during hypothermia, while depolarization seems largely unaffected during initial cooling. Efforts to provide evidence-based information for anti-arrhythmic treatment during hypothermia and rewarming is largely derived from experimental models. The underlying, heterogenic effect of moderate hypothermia; i.e. cardiac depolarization largely unaffected by cooling, while repolarization is prolonged, could be a pro-arrhythmic substrate that is worsened by QT-prolonging drugs. Consequently, treatment of accidental hypothermia patients and use of therapeutic hypothermia is complicated by drugs of non-cardiac indication that prolong the QT interval, e.g. a wide range of antidepressants, antipsychotics, antibiotics, and methadone. 112 On this background, it is vital to monitor cardiac electrophysiology closely in hypothermic patients. Administering cardioactive drugs should be carried out with great caution during rewarming. Medication that prolongs repolarization (increases QT-interval) or promotes cardiac excitation should largely be avoided in accidental hypothermia-patients in sinus rhythm. Before and during therapeutic hypothermia, clinicians should consider dose-reduction of such drugs. Monitoring their serum concentrations during prolonged therapeutic hypothermia is indicated, as drug metabolism is altered by cooling, increasing the risk for cardiotoxic effects. Further, the profound absence of experimental and clinical evidence for anti-arrhythmic treatment in hypothermic patients, yields a demand for translational and clinical studies to lay foundation for clinical guidelines.
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